PLON Pharmsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-04-28
Share capital
5 100,00 PLN
Activity description

PLON Pharm is a Polish producer of liquid dietary supplements, offering the Complex, Solo and PlonVita ranges as well as cold-pressed oils. Its products include Cytra 1000 vitamin C, Pasout Complex with mugwort, Miodunka Lekarska Solo and Lion’s Mane Solo.

Registered address
ul. Cyfrowa 6, 71-441 Szczecin, Poland
Website
plonpharm.plWebsite active
Social media
Electronic delivery address
AE:PL-37056-47820-UEFUS-28

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 524.79kMedianUSD 782.27kAverageUSD 24.03m
Net profit
This companyUSD 195.52kMedianUSD 7.91kAverageUSD 2.59m
Operating costs
This companyUSD 307.82kMedianUSD 723.93kAverageUSD 19.92m
Assets
This companyUSD 246.82kMedianUSD 800.34kAverageUSD 29.11m

Bank accounts

Registered as a VAT taxpayer on 2021-06-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,532
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$970

Tenders

No recorded participation in tenders.

Authorized Representatives

Paweł Andrzej Djaczenko – Management Board Member
Tomasz Bogusław Lipiński – Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Paweł Andrzej Djaczenko (29)
46$621.2945.098%
Tomasz Bogusław Lipiński (43)
46$621.2945.098%
Others
10$135.069.804%

Beneficial owners

Person

Competitors

Name
Actifarmsp. z o.o.
Uropharmasp. z o.o.
Natur DayS.A.
Hauster sp. z o.o.sp. k.
Biotriosp. z o.o.
Inner Harmonysp. z o.o.
Vilowaysp. z o.o.
Biovitalium Polskasp. z o.o.

FAQ

Last updated: 2026-07-04